Moses Joloba

Jun 14, 2023 | microbiologyresearch.org | BEATRICE ACHAN |Benon B. Asiimwe |Moses Joloba |Mourad Gumusboga

Introduction. Drug resistant tuberculosis remains a worldwide problem that requires prompt diagnosis. Hypothesis/Gap statement. The WHO recommended direct rapid Xpert MTB/RIF is prohibitively costly therefore there is a need to validate a rapid affordable DST for use in low- and middle-income settings. Aim. The technical performance and time to results of a simple direct microscopy-based slide DST (SDST) assay for diagnosis of rifampicin-resistant TB was evaluated in Uganda. Methodology.